CVS Health Corporation $CVS Shares Sold by Wincap Financial LLC

Wincap Financial LLC lessened its position in shares of CVS Health Corporation (NYSE:CVS) by 86.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,672 shares of the pharmacy operator’s stock after selling 17,761 shares during the quarter. Wincap Financial LLC’s holdings in CVS Health were worth $212,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the business. Harbor Capital Advisors Inc. increased its stake in CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 142 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in shares of CVS Health by 407.2% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 281 shares during the last quarter. Corundum Trust Company INC purchased a new position in shares of CVS Health during the 3rd quarter worth $29,000. Front Row Advisors LLC increased its position in shares of CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 371 shares during the last quarter. Finally, GoalVest Advisory LLC purchased a new stake in CVS Health in the 4th quarter valued at about $32,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have commented on CVS. Truist Financial set a $100.00 target price on shares of CVS Health in a research report on Wednesday, December 10th. Piper Sandler reissued an “overweight” rating and issued a $101.00 price target (up from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. UBS Group reaffirmed an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Bank of America dropped their target price on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a report on Tuesday, January 27th. Finally, JPMorgan Chase & Co. upped their price target on CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 17th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $95.05.

CVS Health Stock Down 1.5%

Shares of NYSE:CVS opened at $70.08 on Friday. The firm has a market capitalization of $89.16 billion, a PE ratio of 50.79, a price-to-earnings-growth ratio of 0.74 and a beta of 0.49. CVS Health Corporation has a 1 year low of $58.35 and a 1 year high of $85.15. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The firm’s 50-day moving average is $76.62 and its two-hundred day moving average is $77.73.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The firm had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. During the same quarter in the previous year, the business posted $1.19 earnings per share. The business’s quarterly revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd will be paid a $0.665 dividend. The ex-dividend date is Thursday, April 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.8%. CVS Health’s payout ratio is 192.75%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.